Literature DB >> 28389404

Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.

Chandran Anusha1, Thangarajan Sumathi2, Leena Dennis Joseph3.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra which is associated with oxidative stress, neuroinflammation and apoptosis. Apigenin (AGN), a non-mutagenic flavone found in fruits and vegetables, exhibits a variety of biological effects including anti-apoptotic, anti-inflammatory, and free radical scavenging activities. The current study was aimed to investigate the neuroprotective effects and molecular mechanisms of AGN in a rat model of PD induced by rotenone (ROT). Unilateral stereotaxic intranigral infusion of ROT caused the loss of tyrosine hydroxylase (TH) immunoreactivity in striatum and substantia nigra. AGN treatment (10 and 20 mg/kg, i.p.) showed a significant improvement in behavioral, biochemical and mitochondrial enzyme activities as compared to ROT exposed rats. The mRNA expression of inflammatory markers and neurotrophic factors was quantified by reverse transcriptase polymerase chain reaction (RT-PCR). Administration of AGN significantly attenuated the upregulation of NF-κB gene expression in ROT induced group and prevented the neuroinflammation in substantia nigra pars compacta (SNpc). Further, AGN inhibited the release of pro-inflammatory cytokines TNF- α, IL-6 and pro-inflammatory enzyme iNOS-1 induced by ROT. Additionally, AGN prevents the reduction of neurotrophic factors BDNF and GDNF mRNA expression in ROT lesioned rats. Immunoblot results illustrated that AGN treatment downregulated α-synuclein aggregation and upregulated the TH protein expression as well as dopamine D2 receptor (D2R) expression in ROT lesioned rats. Thus, the present findings collectively suggest that AGN exerts its neuroprotection in ROT model of PD and may act as an effective agent for treatment of PD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apigenin; Inflammatory cytokines; Parkinson's disease; Rotenone; α-synuclein

Mesh:

Substances:

Year:  2017        PMID: 28389404     DOI: 10.1016/j.cbi.2017.03.016

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  35 in total

1.  Neuroprotective Effects of Filgrastim in Rotenone-Induced Parkinson's Disease in Rats: Insights into its Anti-Inflammatory, Neurotrophic, and Antiapoptotic Effects.

Authors:  Mariama S Azmy; Esther T Menze; Reem N El-Naga; Mariane G Tadros
Journal:  Mol Neurobiol       Date:  2018-01-11       Impact factor: 5.590

2.  Rifampicin Prevents SH-SY5Y Cells from Rotenone-Induced Apoptosis via the PI3K/Akt/GSK-3β/CREB Signaling Pathway.

Authors:  Xia Wu; Yanran Liang; Xiuna Jing; Danyu Lin; Ying Chen; Tianen Zhou; Sudan Peng; Dezhi Zheng; Zhifen Zeng; Ming Lei; Kaixun Huang; Enxiang Tao
Journal:  Neurochem Res       Date:  2018-02-12       Impact factor: 3.996

3.  Protective Effect of Apigenin on Acrylonitrile-Induced Inflammation and Apoptosis in Testicular Cells via the NF-κB Pathway in Rats.

Authors:  Yuhui Dang; Zhilan Li; Qian Wei; Ruiping Zhang; Hongli Xue; Yingmei Zhang
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

4.  Protective Effect of (-)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats.

Authors:  Hsiang-Chien Tseng; Mao-Hsien Wang; Kuo-Chi Chang; Hung-Sheng Soung; Chih-Hsiang Fang; Yi-Wen Lin; Keng-Yuan Li; Chih-Chuan Yang; Cheng-Chia Tsai
Journal:  Neurotox Res       Date:  2019-12-06       Impact factor: 3.911

5.  Sex Differences in Rotenone Sensitivity Reflect the Male-to-Female Ratio in Human Parkinson's Disease Incidence.

Authors:  Briana R De Miranda; Marco Fazzari; Emily M Rocha; Sandra Castro; J Timothy Greenamyre
Journal:  Toxicol Sci       Date:  2019-07-01       Impact factor: 4.849

Review 6.  Therapeutic benefits of flavonoids against neuroinflammation: a systematic review.

Authors:  Ann Maria Alex; Mahalakshmi Arehally Marappa; Suresh Joghee; Saravana Babu Chidambaram
Journal:  Inflammopharmacology       Date:  2022-01-15       Impact factor: 4.473

7.  L-Theanine Ameliorated Rotenone-Induced Parkinsonism-like Symptoms in Rats.

Authors:  Cheng-Neng Chen; Mao-Hsien Wang; Hung-Sheng Soung; Shu-Mei Chen; Chih-Hsiang Fang; Yi-Wen Lin; Hsiang-Chien Tseng
Journal:  Neurotox Res       Date:  2022-01-06       Impact factor: 3.911

8.  Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.

Authors:  Faycal Guedj; Ashley E Siegel; Jeroen L A Pennings; Fatimah Alsebaa; Lauren J Massingham; Umadevi Tantravahi; Diana W Bianchi
Journal:  Am J Hum Genet       Date:  2020-10-23       Impact factor: 11.025

9.  Araucaria angustifolia (Bertol.) Kuntze has neuroprotective action through mitochondrial modulation in dopaminergic SH-SY5Y cells.

Authors:  Catia Santos Branco; Angela Duong; Alencar Kolinski Machado; Abbie Wu; Gustavo Scola; Ana Cristina Andreazza; Mirian Salvador
Journal:  Mol Biol Rep       Date:  2019-08-26       Impact factor: 2.316

10.  Methanolic extracts of a selected Egyptian Vicia faba cultivar mitigate the oxidative/inflammatory burden and afford neuroprotection in a mouse model of Parkinson's disease.

Authors:  Essam Abdel-Sattar; Engy A Mahrous; Mareena M Thabet; Dina M Yousry Elnaggar; Amal M Youssef; Reda Elhawary; Sawsan A Zaitone; Antonio Segura-Carretero; Reham Hassan Mekky
Journal:  Inflammopharmacology       Date:  2020-10-28       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.